Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02358876 · ClinicalTrials.gov registry record
BradyXplore Phase II: Bradykinesia Feature Extraction System
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 32
- Enrollment target
NCT02358876 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 32 participants.
The verdict
NCT02358876 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
Study objectives are to improve motion sensor algorithms for measuring bradykinesia in the clinic and the home, evaluate test-retest reliability of motion sensor algorithms for measuring bradykinesia compared to clinician raters, determine if participant-perceived symptom severities correlate with motion sensor measures, determine if speed, amplitude, and rhythm fluctuate differentially throughout the day in individuals with implanted deep brain stimulation systems, receive feedback on the usability of Kinesia One, and evaluate Kinesia One compliance in the home.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02358876
The ClinicalTrials.gov registry entry for NCT02358876 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Great Lakes NeuroTechnologies, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02358876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02358876 about?
NCT02358876 is a clinical study titled "BradyXplore Phase II: Bradykinesia Feature Extraction System". Study objectives are to improve motion sensor algorithms for measuring bradykinesia in the clinic and the home, evaluate test-retest reliability of motion sensor algorithms for measuring bradykinesia compared to clinician raters, determine if participant-perceived symptom severities correlate with m...
What is the current status of trial NCT02358876?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2015-02. Estimated completion is 2015-07.
Who is sponsoring clinical trial NCT02358876?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.